Clinical Trial Update: CD7 CAR-T Cell Therapy Targeting CD7-positive Relapsed/Refractory T Cell Lymphoma/Acute Leukemia [NA]

View source ↗

Summary

A clinical trial evaluating a CD7-targeted CAR-T cell therapy for relapsed/refractory CD7-positive T-cell lymphoma and CD7-positive acute lymphoblastic leukemia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• T-cell Lymphoma

Drugs mentioned

• CD7 CAR-T cell therapy

Snippet

Sponsor: Qi deng | Conditions: CD7+ Lymphoma, CD7+ Acute Leukemia | NA | Status: NOT_YET_RECRUITING